Abstract
This before-and-after cohort analysis assesses whether implementing a recommendation of antenatal magnesium use at an institutional level in 2009 resulted in fewer subsequent cases of moderate or severe cerebral palsy.
Publication types
-
Comparative Study
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Cerebral Palsy / diagnosis
-
Cerebral Palsy / epidemiology
-
Cerebral Palsy / prevention & control*
-
Drug Administration Schedule
-
Female
-
Follow-Up Studies
-
Humans
-
Infant, Newborn
-
Logistic Models
-
Magnesium Sulfate / therapeutic use*
-
Male
-
Neuroprotective Agents / therapeutic use*
-
Ohio / epidemiology
-
Pregnancy
-
Premature Birth
-
Prenatal Care / methods*
-
Retrospective Studies
-
Severity of Illness Index*
-
Treatment Outcome
Substances
-
Neuroprotective Agents
-
Magnesium Sulfate